Mydecine Innovations Group Inc (MYCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 10 | 129 | 235 | 90 |
| Accounts receivable | 193 | 207 | -180 | -191 | -34 |
| Other Working Capital | 2,363 | 5,297 | 8,211 | -4,593 | 1,772 |
| Other Operating Activity | -2,593 | -9,731 | -16,588 | -19,503 | -8,953 |
| Operating Cash Flow | $-37 | $-4,217 | $-8,428 | $-24,052 | $-7,124 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | -35 | -404 | -413 |
| Net Acquisitions | N/A | 0 | -2 | 0 | 504 |
| Sale Of Investment | 0 | 525 | N/A | N/A | N/A |
| Purchase Sale Intangibles | 0 | N/A | N/A | 0 | -112 |
| Other Investing Activity | 0 | 0 | 0 | -69 | -552 |
| Investing Cash Flow | $0 | $525 | $-38 | $-474 | $-573 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 110 | 73 | N/A | N/A |
| Debt Issued | N/A | N/A | 0 | 5,500 | 4,700 |
| Debt Repayment | N/A | N/A | N/A | 0 | -100 |
| Common Stock Issued | 0 | 3,608 | 6,908 | 15,333 | 4,690 |
| Other Financing Activity | 0 | 0 | 0 | 2,998 | 633 |
| Financing Cash Flow | $0 | $3,718 | $6,981 | $23,831 | $9,923 |
| Exchange Rate Effect | N/A | N/A | N/A | 0 | -53 |
| Beginning Cash Position | 38 | 11 | 1,495 | 2,191 | 18 |
| End Cash Position | 0 | 38 | 11 | 1,495 | 2,191 |
| Net Cash Flow | $-37 | $27 | $-1,484 | $-695 | $2,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37 | -4,217 | -8,428 | -24,052 | -7,124 |
| Capital Expenditure | N/A | N/A | -35 | -404 | -525 |
| Free Cash Flow | -37 | -4,217 | -8,463 | -24,457 | -7,649 |